- In March 2024, the newly launched V30 Pro and upcoming X-series products in 2024 highlight the continued collaboration between Vivo and ZEISS in mobile imaging, promising future innovations for users worldwide. This collaboration will strengthen the company’s position in the market by enhancing its technological offerings and attracting a broader customer base
- In February 2024, Bruker Corporation (Nasdaq: BRKR) has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems, enhancing its BioSpin Preclinical Imaging division. This acquisition expands Bruker's preclinical solutions for disease research, positioning the company for growth in the expanding imaging market
- In September 2023, Revvity, Inc. has launched an enhanced imaging portfolio, featuring the next-generation IVIS Spectrum 2 and IVIS SpectrumCT 2 systems, boosting versatility and sensitivity in preclinical research. This innovation will help the company strengthen its market position and meet growing demand for advanced in vivo optical imaging solutions
